Biology subjects

Held, L.

Publications and source records attributed to Held, L..

4 recordsLinked to original sources

bioRxiv2026

Large-Scale Assessment of Animal-to-Human Drug Translation Using Natural Language Processing

BackgroundLarge-scale estimates of animal-to-human drug translation and the study characteristics associated with successful translation remain limited. The expanding preclinical literature also challenges manual evidence synthesis. We developed a natural language processing (NLP) pipeline to structure and link preclinical and clinical evidence at scale. MethodsIn this retrospective meta-research study, we analysed more than 500,000 neuroscience-related animal drug studies from PubMed and linked them to clinical trial and regulatory approval data. NLP methods extracted drug, disease, and experimental design characteristics from abstracts and full texts. Translation was defined as progression to completed phase III/IV trials or regulatory approval. Logistic regression assessed associations between preclinical study characteristics and successful translation. FindingsAmong 291,624 drug entities identified in animal studies, 6{middle dot}7% entered clinical development and 3{middle dot}1% reached phase III/IV trials or regulatory approval. At the drug-disease level, 4{middle dot}4% entered clinical development and 1{middle dot}9% achieved translation. Restricting analyses to successfully linked ontology entities increased estimates to 11{middle dot}3% and 4{middle dot}1%, respectively. Male-only animal studies predominated, whereas reporting of randomisation, blinding, and sample size calculations remained limited. Testing across multiple species and reporting blinding were associated with higher odds of successful translation. InterpretationOnly a minority of interventions tested in animals progress to advanced clinical development or regulatory approval. Greater species diversity and blinding were associated with improved translational success. NLP-based evidence synthesis may support scalable evaluation of translational research and identification of potentially modifiable research practices. FundingSwiss National Science Foundation, UZH Digital Entrepreneurship Fellowship, Universities Federation for Animal Welfare. Research in contextO_ST_ABSEvidence before this studyC_ST_ABSWe searched the literature for studies quantifying large-scale animal-to-human translation and factors associated with successful translation. Existing work was mainly limited to specific diseases, interventions, or manually curated datasets, and large-scale linkage of animal and clinical evidence remained limited. Added value of this studyWe developed a natural language processing pipeline linking more than 500,000 animal studies to clinical trial and regulatory approval data. The study provides large-scale estimates of translation and identifies experimental characteristics associated with successful translation. Implications of all the available evidenceThe findings suggest that only a minority of interventions tested in animals progress to advanced clinical development or regulatory approval. Greater species diversity and reporting of blinding were associated with improved translation. Automated evidence synthesis may support more systematic evaluation of translational research practices.

bioinformatics↗

bioRxiv2026

A rapid, sensitive, and quantitative high plex biomarker digital detection platform enabled by Hypercoding

Low-cost, multiplexed, and automated assays are needed to make omic technologies more broadly accessible in clinical, research, and commercial settings. We present Hypercoding, a scalable technology for detection and quantitation of multi-omic targets. Drawing from data reliability methods in the telecommunications field, Hypercoding uses fluorescent signals from hybridization with an error-correcting code to enable detection of high-plexity targets from biological samples, such as human DNA. In the presence of the target, a linear DNA construct is circularized, immobilized, and amplified to enable single-molecule detection of a target via rapid readout cycles within a 96-well plate. We demonstrate capability for >10,000 code plexity and accurate (98.7%) genotyping of 209 pharmacogenomic variants. Furthermore, we show computation of copy number variation with whole chromosome and sub-gene resolution, as well as quantitation of target abundance down to 10 fM sensitivity with a dynamic range of up to 10 logs.

genomics↗

bioRxiv2021

Defensive freezing and its relation to approach-avoidance decision-making under threat

Successful responding to acutely threatening situations requires adequate approach-avoidance decisions. However, it is unclear how threat-induced states-like freezing-related bradycardia-impact the weighing of the potential outcomes of such value-based decisions. Insight into the underlying computations is essential, not only to improve our models of decision-making but also to improve interventions for maladaptive decisions, for instance in anxiety patients and first-responders who frequently have to make decisions under acute threat. Forty-two participants made passive and active approach-avoidance decisions under threat-of-shock when confronted with mixed outcome-prospects (i.e., varying money and shock amounts). Choice behavior was best predicted by a model including individual action-tendencies and bradycardia, beyond the subjective value of the outcome. Moreover, threat-related bradycardia interacted with subjective value, depending on the action-context (i.e., passive vs. active). Specifically, in action-contexts incongruent with participants intrinsic action-tendencies, strong freezers showed diminished effects of subjective value on choice. These findings illustrate the relevance of testing approach-avoidance decisions in relatively ecologically valid conditions of acute and primarily reinforced threat. These mechanistic insights into approach-avoidance conflict-resolution may inspire biofeedback-related techniques to optimize decision-making under threat. Critically, the findings demonstrate the relevance of incorporating internal psychophysiological states and external action-contexts into models of approach-avoidance decision-making.

neuroscience↗

bioRxiv2017

Probabilistic forecasting in infectious disease epidemiology: The thirteenth Armitage lecture

Routine surveillance of notifiable infectious diseases gives rise to daily or weekly counts of reported cases stratified by region and age group. From a public health perspective, forecasts of infectious disease spread are of central importance. We argue that such forecasts need to properly incorporate the attached uncertainty, so should be probabilistic in nature. However, forecasts also need to take into account temporal dependencies inherent to communicable diseases, spatial dynamics through human travel, and social contact patterns between age groups. We describe a multivariate time series model for weekly surveillance counts on norovirus gastroenteritis from the 12 city districts of Berlin, in six age groups, from week 2011/27 to week 2015/26. The following year (2015/27 to 2016/26) is used to assess the quality of the predictions. Probabilistic forecasts of the total number of cases can be derived through Monte Carlo simulation, but first and second moments are also available analytically. Final size forecasts as well as multivariate forecasts of the total number of cases by age group, by district, and by week are compared across different models of varying complexity. This leads to a more general discussion of issues regarding modelling, prediction and evaluation of public health surveillance data.

epidemiology↗